E-LIB Suche - Ergebnisse für: Bethge, Wolfgang

1

An aggressive mediastinal EBV‐associated large B cell lymph..:

Kurz, Katrin S ; Noerenberg, Daniel ; Schaich, Markus...
Histopathology. 85 (2024) 1 - p. 195-197 , 2024

Link: https://doi.org/10.1111/..

2

Case report: Sequential inotuzumab, blinatumomab, and chemo..:

Beer, Sina A. ; Bethge, Wolfgang ; Faul, Christoph..
eJHaem. 5 (2024) 3 - p. 620-623 , 2024

Link: https://doi.org/10.1002/..

3

Fludarabine-treosulfan versus fludarabine-melphalan or busu..:

Beelen, Dietrich Wilhelm ; Iacobelli, Simona ; Koster, Linda...
Bone Marrow Transplantation. 59 (2024) 5 - p. 670-679 , 2024

Link: https://doi.org/10.1038/..

4

Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapse..:

Gagelmann, Nico ; Bishop, Michael ; Ayuk, Francis...
Transplantation and Cellular Therapy. 30 (2024) 6 - p. 584.e1-584.e13 , 2024

Link: https://doi.org/10.1016/..

5

Allogeneic hematopoietic cell transplantation for older pat..:

Maffini, Enrico ; Labopin, Myriam ; Kröger, Nicolaus...
Bone Marrow Transplantation. 59 (2024) 7 - p. 983-990 , 2024

Link: https://doi.org/10.1038/..

6

Allogeneic hematopoietic cell transplantation for adult met..:

Riedel, Andreas ; Faul, Christoph ; Reuss, Kristina...
Blood Advances. 8 (2024) 6 - p. 1504-1508 , 2024

Link: https://doi.org/10.1182/..

7

Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell th..:

Obermaier, Benedikt ; Braun, Christiane ; Hensen, Luca...
Transplant Infectious Disease. , 2024

Link: https://doi.org/10.1111/..

8

Applying the EHA/EBMT grading for ICAHT after CAR-T: compar..:

Rejeski, Kai ; Wang, Yucai ; Hansen, Doris K....
Blood Advances. 8 (2024) 8 - p. 1857-1868 , 2024

Link: https://doi.org/10.1182/..

9

Management of Patients Undergoing CAR-T Cell Therapy in Ger..:

Penack, Olaf ; Dreger, Peter ; Ajib, Salem...
Oncology Research and Treatment. 47 (2024) 3 - p. 65-75 , 2024

Link: https://doi.org/10.1159/..

10

Remission induction versus immediate allogeneic haematopoie..:

Stelljes, Matthias ; Middeke, Jan Moritz ; Bug, Gesine...
The Lancet Haematology. 11 (2024) 5 - p. e324-e335 , 2024

Link: https://doi.org/10.1016/..

11

Impact of busulfan versus treosulfan dose intensity in myel..:

Gagelmann, Nico ; Schuh, Claudia ; Flossdorf, Sarah...
American Journal of Hematology. 99 (2024) 8 - p. 1540-1549 , 2024

Link: https://doi.org/10.1002/..

12

Reduced intensity versus myeloablative conditioning for MDS..:

Niederwieser, Christian ; Iacobelli, Simona ; Franke, Georg-Nikolaus...
Bone Marrow Transplantation. , 2024

Link: https://doi.org/10.1038/..

13

Outcomes of axicabtagene ciloleucel in PMBCL compare favora..:

Schubert, Maria-Luisa ; Bethge, Wolfgang A. ; Ayuk, Francis A....
Blood Advances. 7 (2023) 20 - p. 6191-6195 , 2023

Link: https://doi.org/10.1182/..

14

Total body irradiation versus busulfan based intermediate i..:

Hirschbühl, Klaus ; Labopin, Myriam ; Polge, Emmanuelle...
Bone Marrow Transplantation. 58 (2023) 8 - p. 874-880 , 2023

Link: https://doi.org/10.1038/..

15

P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOUR..:

Haupt, Maik ; Jäkel, Nadja ; Wachsmuth, Maria...
HemaSphere. 7 (2023) S3 - p. e85305e4 , 2023

Link: https://doi.org/10.1097/..